Glioblastoma Multiforme of Brain: Clinical Trials

34 trials for Glioblastoma Multiforme of Brain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 10 recruiting, 5 terminated, 4 unknown. 15 Phase 1, 10 Phase 2, 4 Early Phase 1, 3 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 115Completed 4, Recruiting 3, Terminated 3, Unknown 3, Active not recruiting 1, Suspended 1
Phase 210Completed 6, Active not recruiting 2, Recruiting 1, Unknown 1
Early Phase 14Terminated 2, Active not recruiting 1, Recruiting 1
Not applicable3Recruiting 2, Enrolling by invitation 1
Phase 32Active not recruiting 1, Unknown 1

Follow Glioblastoma Multiforme of Brain: new trials by email Literature Review of Glioblastoma Multiforme of Brain trials Research Report on Glioblastoma Multiforme of Brain

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
GLIX1 - Glioblastoma Multiforme of Brain, Glioma
Phase 1RecruitingTetragon Biosciences Ltd302026-04-202026-11-04
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Ruxolitinib, Temozolomide, Radiation Therapy - Glioblastoma, Brain Cancer
Phase 2RecruitingBaptist Health South Florida1902025-12-032026-10-02
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
15.GPC3-CAR T cells - Glioblastoma Multiforme of Brain
Phase 1RecruitingBaylor College of Medicine272025-10-102026-09-30
Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy
Focused Ultrasound Next Generation Dome Helmet, Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension - GBM, Glioblastoma Multiforme (GBM)
Phase 1RecruitingSunnybrook Health Sciences Centre102025-06-042025-09-17
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
Fluciclovine F18 - Glioblastoma, Recurrent Glioblastoma
Early Phase 1RecruitingAbramson Cancer Center at Penn Medicine152025-05-012026-09-09
Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
C134 Re-Administration - Recurrent Malignant Glioma, Glioblastoma Multiforme of Brain
Phase 1TerminatedUniversity of Alabama at Birmingham12024-06-212026-01-22
Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
Cisplatin Plus Temozolomide, Temozolomide - Glioblastoma Multiforme of Brain
Phase 1 / Phase 2UnknownZhongnan Hospital602024-01-012024-01-02
Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
TVI-Brain-1, Standard of Care, Radiotherapy - Glioblastoma Multiforme of Brain
Phase 2 / Phase 3Active not recruitingTVAX Biomedical1202023-12-272026-09-29
CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
CHM-1101 CAR-T cells - Glioblastoma Multiforme of Brain
Phase 1TerminatedChimeric Therapeutics12023-06-062026-06-29
Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
photochemotherapy using 3-(1-Butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester(Photobac®) - Glioblastoma Multiforme of Brain, Glioma, Sarcomatous
Phase 1UnknownPhotolitec LLC302023-04-112023-04-13
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Laparoscopically harvested omental tissue autograft - Glioma, Glioma, Malignant
Not applicableRecruitingNorthwell Health102023-04-042026-06-01
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
C5252 - Solid Tumor, Glioblastoma
Phase 1UnknownImmVira Pharma Co. Ltd512023-03-152022-10-12
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Re-resection, Temozolomide, Lomustine - Glioblastoma, Glioblastoma Multiforme
RecruitingJasper Gerritsen4642023-01-012024-02-28
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Tumor resection, Tumor biopsy - Glioblastoma, Glioblastoma, IDH-wildtype
RecruitingJasper Gerritsen5642023-01-012023-11-27
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Awake mapping under local anesthesia, Asleep mapping under general anesthesia, Resection under general anesthesia without mapping - Glioblastoma, IDH-wildtype, Glioblastoma
RecruitingErasmus Medical Center2252023-01-012024-02-22
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial
Posaconazole Pill - Glioblastoma, Glioblastoma Multiforme
Early Phase 1TerminatedMilton S. Hershey Medical Center72022-05-132026-01-23
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
Ketoconazole - Glioblastoma, Glioblastoma Multiforme
Early Phase 1TerminatedMilton S. Hershey Medical Center12022-05-112026-01-07
[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
Positron Emission Tomography-Computerised Tomography (PET-CT) - Glioblastoma Multiforme of Brain
CompletedImperial College London32022-04-192025-04-09
The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
Circuit-based resistance exercise (CRT) - Glioblastoma Multiforme of Brain, Brain Cancer
Not applicableEnrolling by invitationNova Scotia Health Authority242022-03-012026-05-29
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
Niraparib, Radiation therapy - Glioblastoma, Glioblastoma Multiforme
Early Phase 1Active not recruitingNader Sanai422021-10-292026-03-09

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Glioblastoma (21)  ·  Brain Neoplasms (13)  ·  Glioma (7)  ·  Astrocytoma (3)  ·  Recurrence (2)  ·  Gliosarcoma (1)  ·  Motor Activity (1)  ·  Muscular Diseases (1)  ·  Postoperative Complications (1)

Broader conditions

Neoplasms (25)  ·  Neoplasms by Histologic Type (23)  ·  Neoplasms, Germ Cell and Embryonal (23)  ·  Neoplasms, Glandular and Epithelial (23)  ·  Neoplasms, Nerve Tissue (23)  ·  Neoplasms, Neuroepithelial (23)  ·  Neuroectodermal Tumors (23)  ·  Astrocytoma (18)  ·  Glioma (16)  ·  Brain Diseases (13)  ·  Central Nervous System Diseases (13)  ·  Central Nervous System Neoplasms (13)  ·  Neoplasms by Site (13)  ·  Nervous System Diseases (13)  ·  Nervous System Neoplasms (13)

Interventions

Temozolomide (6)  ·  Radiotherapy (3)  ·  Chlorotoxin (1)  ·  Cisplatin (1)  ·  Diet, Ketogenic (1)  ·  Drug Therapy (1)  ·  Evoked Potentials (1)  ·  Immunotherapy (1)  ·  Ketoconazole (1)  ·  Lomustine (1)  ·  Oncolytic Virotherapy (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  Re-Irradiation (1)  ·  Standard of Care (1)  ·  Therapies, Investigational (1)

Sponsors

Jasper Gerritsen (3)  ·  Milton S. Hershey Medical Center (2)  ·  Northwell Health (2)  ·  University of Alabama at Birmingham (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Baptist Health South Florida (1)  ·  Baylor College of Medicine (1)  ·  Beijing Tiantan Hospital (1)  ·  Burzynski Research Institute (1)  ·  Chimeric Therapeutics (1)  ·  Clinique Neuro-Outaouais (1)  ·  Emory University (1)  ·  Erasmus Medical Center (1)  ·  ImmVira Pharma Co. Ltd (1)  ·  Imperial College London (1)

Countries

United States (21)  ·  Belgium (5)  ·  Germany (4)  ·  Netherlands (4)  ·  Switzerland (4)  ·  Canada (3)  ·  China (2)  ·  Iran (1)  ·  United Kingdom (1)

Top investigators

Jasper Gerritsen, MD PhD (3)  ·  James Markert, MD (2)  ·  John Boockvar, MD (2)  ·  Ali Nabavizadeh, MD (1)  ·  Alireza Mansouri (1)  ·  Alireza Mansouri, MD (1)  ·  Arnaud Vincent, MD PhD (1)  ·  Ganesh Rao, MD (1)  ·  Gary Wood, PhD (1)  ·  Ghazaleh Tabatabai, Prof (1)  ·  Hui-Kuo Shu, MD, PhD (1)  ·  Kazem Anvari, M.D. (1)  ·  Lung-Ji Chang, PhD (1)  ·  Mahdi Silanian Toosi, M.D. (1)

Results publications

PMID 12436090, PMID 12743250, PMID 12893641, PMID 15717053, PMID 15792886, PMID 18798293, PMID 19664713, PMID 19682584, PMID 19833552, PMID 21924290, PMID 22037136, PMID 22629405, PMID 23388348, PMID 25117977, PMID 31676314, PMID 33292598, PMID 34290067, PMID 34604752, PMID 35507403, PMID 35569489, PMID 35861778, PMID 36549916, PMID 36617554, PMID 39260848, PMID 404164, PMID 42401550, PMID 42494994

NIH funding

F30CA206291 (1), P30CA138292 (1), R01CA222903 (1), R03CA255992 (1), R21NS100244 (1), R44CA247127 (1), U01CA172027 (1)